Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Spleen tyrosine kinase-Phosphoinositide 3-kinase-Nuclear factor kappa B (Syk-PI3K-NF-κB) signaling pathway is a critical intracellular cascade that mediates the activation and maturation of dendritic cells (DCs) in response to various stimuli, particularly through C-type lectin receptors (CLRs) like Dectin-1 and Dectin-2 [PMID: 17448156, 21525984]. Upon ligand binding, Syk is recruited to phosphorylated immunoreceptor tyrosine-based activation motifs (ITAMs), triggering downstream activation of PI3K [PMID: 19234452]. This cascade ultimately leads to the activation and nuclear translocation of NF-κB, which drives the expression of pro-inflammatory cytokines and costimulatory molecules necessary for T-cell priming [PMID: 23601688]. This pathway plays a pivotal role in orchestrating innate and adaptive immune responses against fungal and bacterial pathogens [PMID: 28978534]. Pharmacological targeting of individual components, such as Syk or PI3K, is a therapeutic strategy used to modulate immune responses in inflammatory, autoimmune, and hematological disorders [PMID: 30333114].
Inhibition of Spleen tyrosine kinase (Syk) activity, inhibition of Phosphoinositide 3-kinase (PI3K) isoforms, or inhibition of the NF-kappaB activation pathway to modulate immune cell function.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spleen tyrosine kinase-Phosphoinositide 3-kinase-Nuclear factor kappa B signaling pathway (Syk-PI3K-NF-κB pathway).